Uveal Melanoma Latest Advances

Find the Latest Research About Uveal Melanoma

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6772 publications

Comparative Proteomic Profiling of Microdissected Spindle and Epithelioid Uveal Melanoma Subtypes.

Comparative Proteomic Profiling of Microdissected Spindle and Epithelioid Uveal Melanoma Subtypes.

Journal: Investigative ophthalmology & visual science

Published: April 15, 2026

Transforming tumor cells into professional antigen-presenting cells using poly(β-amino ester) nanoparticles to deliver CD80-encoding mRNA.

Transforming tumor cells into professional antigen-presenting cells using poly(β-amino ester) nanoparticles to deliver CD80-encoding mRNA.

Journal: Nanoscale horizons

Published: April 12, 2026

The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells.

The SCD1 inhibitor aramchol interacts with regorafenib and metformin to kill tumor cells.

Journal: Oncotarget

Published: April 09, 2026

Plaque Radiotherapy for Posterior Uveal Melanoma in 4000 Eyes: Analysis of ≥15-Letter Visual Acuity Loss in the Pre-Anti-VEGF Era.

Plaque Radiotherapy for Posterior Uveal Melanoma in 4000 Eyes: Analysis of ≥15-Letter Visual Acuity Loss in the Pre-Anti-VEGF Era.

Journal: Retina (Philadelphia, Pa.)

Published: April 06, 2026

Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Journal: Science translational medicine

Published: April 01, 2026

Correction to: Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients.

Correction to: Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients.

Journal: The oncologist

Published: March 23, 2026

Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus.

Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus.

Journal: medRxiv : the preprint server for health sciences

Published: March 23, 2026

Association of clinical and morphological tumor characteristics with the status of chromosomes 1, 3, and 8 in iris melanoma

Association of clinical and morphological tumor characteristics with the status of chromosomes 1, 3, and 8 in iris melanoma

Journal: Vestnik oftalmologii

Published: March 18, 2026

MicroRNA deregulation as a method for assessing the effectiveness of brachytherapy for choroidal melanoma

MicroRNA deregulation as a method for assessing the effectiveness of brachytherapy for choroidal melanoma

Journal: Vestnik oftalmologii

Published: March 18, 2026

Choroidal Tumors

Choroidal Tumors

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: March 17, 2026

Statement of Retraction: MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.

Statement of Retraction: MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.

Journal: Bioengineered

Published: March 12, 2026

The latest in vitro models for novel uveal melanoma drug discovery: how effective are they and what needs to be done?

The latest in vitro models for novel uveal melanoma drug discovery: how effective are they and what needs to be done?

Journal: Expert opinion on drug discovery

Published: March 11, 2026

Showing 1-12 of 6,772

Last Updated: 04/28/2026